alexion rare disease portfolio
In 2026 Alexion presented the largest share of therapeutic classes for rare diseases at the AAN meeting, highlighting that data hubs are not the only drivers of innovation. The claim that a single rare disease data center controls all insight is therefore inaccurate. My experience working with multiple registries confirms
alexion rare disease portfolio
In 2026 Alexion presented the largest share of therapeutic classes for rare diseases at the AAN meeting, highlighting that data hubs are not the only drivers of innovation. The claim that a single rare disease data center controls all insight is therefore inaccurate. My experience working with multiple registries confirms
alexion rare disease portfolio
In 2026 Alexion presented the largest share of therapeutic classes for rare diseases at the AAN meeting, highlighting that data hubs are not the only drivers of innovation. The claim that a single rare disease data center controls all insight is therefore inaccurate. My experience working with multiple registries confirms